• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Algorics announce Dr. Malcolm Burgess as new advisory board member

Algorics announce Dr. Malcolm Burgess as new advisory board member

October 10, 2017
CenterWatch Staff

Algorics, a provider of clinical analytics solutions and software for the global life sciences industry, announced the appointment of Dr. Malcolm Burgess to the Advisory Board of Algorics. Dr. Burgess will help to continue to shape and guide the Algorics Risk Based Monitoring (RBM) strategy working closely with the leadership team.

Dr. Burgess brings more than 40 years’ experience in the Pharmaceutical industry, starting with more than a decade in basic research followed by a move into clinical development. His time in clinical drug development encompassed Biometrics, Data Management, IT, major re-engineering projects, EDC design/implementation and establishing Business Process Optimizations (BPOs). He has extensive experience of working in India and the Far East (especially China and Japan). Most recently he has spent significant time educating sponsors on risk based approaches to quality management and monitoring, and has been instrumental in formulating the technology strategy for RBM adoption for multiple global clients.

Malcolm said of his appointment “I am very pleased to be becoming a member of the Algorics Advisory Board. During my time at ICON I was able to help and guide many early adopters of RBM. I’m convinced that RBM will become the standard approach to monitoring clinical trials, just as EDC has for clinical trial data collection and processing. The opportunity to continue working in this space with a premier company such as Algorics is extremely exciting for me.”

Algorics’ Founder and CEO Nithiya Ananthakrishnan commented, “We are very pleased to have Dr. Burgess join our advisory board which is composed of life science and technology strategy specialists.  His vast experience and guidance will be invaluable as we continue to develop and mature as an organization.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing